|
Enrollment barriers of adolescents and young adults (AYA) on the non-chemotherapy arm of ARST1321. |
| |
|
|
| |
|
Consulting or Advisory Role - Epizyme |
Travel, Accommodations, Expenses - Salarius Pharmaceuticals |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Epizyme; Epizyme |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Amgen; Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Incyte; Jazz Pharmaceuticals; Lilly (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Seagen |
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Celgene; Loxo |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Daiichi Sankyo; Epizyme; Immune Design; Janssen; Lilly; MaxiVax ; Novartis |
Research Funding - Blueprint Medicines (Inst) |
| |
|
Honoraria - Biomet; Daiichi Sankyo |
Travel, Accommodations, Expenses - Biomet; Daiichi Sankyo/Lilly |
| |
|
Research Funding - SARC: Sarcoma Alliance for Research though Collaboration (Inst) |
| |
|
Employment - Limbguard (I) |
Leadership - Limbguard (I) |
Stock and Other Ownership Interests - Limbguard (I) |
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Ignyta; Lilly; Loxo; NanoCarrier |
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Plexxikon (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst) |
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I) |
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Adaptimmune; Agios; Lilly; Macrogenics; More Health |
Expert Testimony - Kilcoyne & Nesbitt |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bayer |
Patents, Royalties, Other Intellectual Property - Amgen (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Bayer |
| |
|
Travel, Accommodations, Expenses - SpringWorks Therapeutics |